Timely identification in boys can help prevent complications related to delayed puberty. Early diagnosis and intervention in men offer improved safeguarding against conditions like osteoporosis.
During a physical examination, your doctor will assess whether your sexual development, including pubic hair, muscle mass, and testes size, aligns with your age. If signs or symptoms of hypogonadism are present, your doctor may conduct a blood test to measure your testosterone levels. Since testosterone levels vary and are typically highest in the morning, blood testing is usually performed early in the day, before 10 a.m., and may be repeated on multiple days.
If tests confirm low testosterone levels, additional investigations can identify whether a testicular disorder or pituitary abnormality is the underlying cause, which may include semen analysis, hormone testing, pituitary imaging, testicular biopsy, or genetic studies.
Treating delayed puberty in boys depends on the underlying cause. Administering testosterone supplementation via injections for three to six months can stimulate puberty and the development of secondary sexual characteristics. These include increased muscle mass, growth of facial and pubic hair, and growth of the penis.
The primary treatment for male hypogonadism typically involves testosterone replacement therapy aimed at restoring testosterone levels to normal. This therapy effectively addresses symptoms such as reduced sexual desire, decreased energy, diminished facial and body hair, and loss of muscle mass and bone density associated with the condition.
For older men experiencing low testosterone levels and hypogonadism symptoms due to aging, the benefits of testosterone replacement therapy are not as conclusively established.
During testosterone replacement therapy, it’s recommended by the Endocrine Society that your doctor regularly assesses treatment efficacy and monitors for potential side effects. Monitoring is particularly crucial during the initial year of treatment and should continue annually thereafter.
In the treatment of hypogonadism, oral testosterone preparations are generally avoided due to the risk of causing severe liver issues and the challenge of maintaining consistent testosterone levels. However, an exception to this is testosterone undecanoate, an oral testosterone replacement therapy approved by the Food and Drug Administration. It’s absorbed through the lymphatic system, potentially circumventing the liver-related concerns associated with other oral testosterone forms.
Alternatively, other preparations can be considered based on factors such as convenience, cost, and insurance coverage including:
Testosterone therapy comes with several potential risks, such as:
When a pituitary issue underlies hypogonadism, administering pituitary hormones can stimulate sperm production and restore fertility. Treatment may involve surgical removal, medication, radiation, or hormone replacement therapy for pituitary tumors.
Restoring fertility in cases of primary hypogonadism can be challenging, but assisted reproductive technology offers options. This includes various techniques designed to assist couples experiencing difficulties conceiving.